David Matly

Vice President, Global Disease Lead at Novartis Oncology
Summary
David Matly is an accomplished professional with a strong educational background and extensive experience in the pharmaceutical and biotechnology industries.
He holds a Master of Business Administration (MBA) from Harvard Business School and a Bachelors of Science in Industrial Engineering from Purdue University.
David currently serves as the Vice President, Global Disease Lead at Novartis Oncology, where he plays a crucial role in leading initiatives related to disease management on a global scale.
Prior to his current position, David held several key roles at Novartis Oncology, including Executive Director for Global Lead Sickle Cell Disease and Director for Global Lead Promacta/Revolade, showcasing his versatility and leadership capabilities.
Before joining Novartis, David gained valuable experience at Eli Lilly and Company, where he held various positions such as US Director for CYRAMZA, US Brand Manager for ERBITUX, Global Brand Manager for EFFIENT, Payer Marketing Consultant, and Senior Sales Representative for Diabetes Care.
Additionally, David has a background in business development, having served as the Vice President of Business Development at Chrono Therapeutics, highlighting his strategic and entrepreneurial mindset.
David Matly's diverse experience across pharmaceutical companies and roles demonstrates his expertise in areas such as global disease management, brand management, marketing, sales, and business development.
His educational qualifications, coupled with his professional achievements, position him as a well-rounded professional with a wealth of knowledge and skills in the healthcare industry.